Os03g0776000 Antibody

What is Os03g0776000 and what role does it play in rice growth regulation?

The protein encoded by Os03g0776000 is subject to post-translational modifications, particularly phosphorylation. According to research findings, GSK2 (a GSK3/SHAGGY-like kinase) can phosphorylate DLT, and brassinolide treatment can induce the dephosphorylation of DLT, leading to the accumulation of dephosphorylated DLT protein . This phosphorylation-dephosphorylation cycle appears to be critical for its function in BR signaling.

How do brassinosteroid signaling components interact with Os03g0776000?

Based on research with related proteins in the brassinosteroid pathway, the interaction between Os03g0776000 and other BR signaling components involves:

• Direct interaction with GSK2, a GSK3/SHAGGY-like kinase that acts as a critical negative regulator of BR signaling in rice

• Phosphorylation by GSK2, which likely inhibits Os03g0776000 activity

• Dephosphorylation in response to brassinolide treatment

• Possible interactions with BZR1, another transcription factor in the BR signaling pathway

Immunological studies have shown that both DLT and BZR1 are substrates of GSK3-like kinase (GSK2), and their phosphorylation status and protein accumulation are regulated by BR signaling . This positions Os03g0776000 as a downstream component in the BR signaling cascade, affecting plant growth and development.

What are the optimal protocols for Western blotting using Os03g0776000 antibodies?

For optimal Western blotting results with Os03g0776000 antibodies, researchers should follow this methodological approach:

• Sample preparation: Extract total protein from rice tissues using a buffer containing:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 1% Triton X-100

  • 1 mM EDTA

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if studying phosphorylation)

• Gel electrophoresis: Separate 20-50 μg of total protein on 8-10% SDS-PAGE gels, as the Os03g0776000 protein is approximately 65 kDa.

• Transfer conditions: Transfer proteins to PVDF membranes at 100V for 1 hour in standard transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol).

• Blocking: Block membranes with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.

• Primary antibody incubation: Dilute Os03g0776000 antibody (e.g., CSB-PA337243XA01OFG ) at 1:1000 to 1:2000 in blocking solution and incubate overnight at 4°C.

• Washing: Wash membranes 3 times with TBST, 10 minutes each.

• Secondary antibody: Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature.

• Detection: Use enhanced chemiluminescence (ECL) for detection.

For studying phosphorylation states, treat duplicate samples with calf intestinal alkaline phosphatase (CIP) prior to SDS-PAGE to identify phosphorylated forms, as demonstrated with DLT protein .

How can immunoprecipitation with Os03g0776000 antibodies be optimized for protein interaction studies?

To optimize immunoprecipitation (IP) with Os03g0776000 antibodies for protein interaction studies, follow this detailed protocol:

• Tissue collection and processing:

  • Harvest 2-3 g of fresh rice tissue

  • Flash-freeze in liquid nitrogen

  • Grind to a fine powder using a pre-chilled mortar and pestle

• Protein extraction buffer:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 1% Triton X-100

  • 0.5% NP-40

  • 1 mM EDTA

  • 10% glycerol

  • 1 mM DTT

  • 1× protease inhibitor cocktail

  • 1× phosphatase inhibitor cocktail

• Extraction procedure:

  • Add 3-4 mL extraction buffer per gram of tissue

  • Homogenize thoroughly

  • Centrifuge at 14,000 × g for 15 minutes at 4°C

  • Collect supernatant

  • Determine protein concentration

• Pre-clearing:

  • Add 50 μL Protein A/G agarose beads per mL of extract

  • Rotate for 1 hour at 4°C

  • Centrifuge at 1,000 × g for 5 minutes

  • Collect supernatant

• Immunoprecipitation:

  • Add 2-5 μg of Os03g0776000 antibody per mg of total protein

  • Incubate overnight at 4°C with gentle rotation

  • Add 50 μL Protein A/G beads

  • Incubate for 3 hours at 4°C with rotation

• Washing:

  • Centrifuge at 1,000 × g for 2 minutes

  • Wash 4 times with IP buffer containing reduced detergent (0.1%)

  • Perform one final wash with detergent-free buffer

• Elution options:

  • For Western blotting: Add 50 μL 2× SDS sample buffer and boil

  • For mass spectrometry: Use non-denaturing elution buffer (e.g., 0.1 M glycine, pH 2.5)

• Analysis of co-immunoprecipitated proteins:

  • Western blotting for known interactors

  • Mass spectrometry for unbiased interaction discovery

Based on studies with related proteins, this protocol should successfully capture Os03g0776000 interactions with proteins like GSK2, as demonstrated for DLT .

What approaches can be used to investigate Os03g0776000 phosphorylation dynamics?

To investigate Os03g0776000 phosphorylation dynamics, employ these methodological approaches:

• Mobility shift detection:

  • Perform SDS-PAGE and Western blotting with Os03g0776000 antibodies

  • Look for bands with reduced mobility (higher molecular weight)

  • Compare patterns across different tissues and treatments

  • Based on research with DLT, phosphorylated Os03g0776000 typically migrates more slowly during electrophoresis

• Phosphatase treatment:

  • Divide protein samples into two aliquots

  • Treat one aliquot with calf intestinal alkaline phosphatase (CIP)

  • Incubate at 37°C for 30 minutes with 10 units of CIP

  • Compare treated and untreated samples by Western blotting

  • Disappearance of higher molecular weight bands confirms phosphorylation

• Hormone treatment time course:

  • Treat rice seedlings or leaf segments with brassinolide (1-10 μM)

  • Collect samples at different time points (0, 15, 30, 60, 120 minutes)

  • Extract proteins and analyze by Western blotting

  • Monitor the ratio of phosphorylated to dephosphorylated forms

  • Research shows that BL treatment leads to conversion of phosphorylated DLT to dephosphorylated form

• In vitro kinase assays:

  • Express and purify recombinant Os03g0776000 protein

  • Incubate with purified GSK2 kinase

  • Add ATP (cold or radioactive)

  • Analyze phosphorylation by Western blotting or autoradiography

• Phosphorylation site mapping:

  • Immunoprecipitate Os03g0776000 from plant tissues

  • Perform mass spectrometry analysis

  • Identify specific phosphorylated residues

  • Compare phosphorylation patterns under different conditions

These approaches can reveal how Os03g0776000 phosphorylation is regulated in response to hormones and during development, providing insights into its function in signaling pathways.

How can protein-protein interactions of Os03g0776000 be identified and characterized?

To identify and characterize protein-protein interactions of Os03g0776000, employ multiple complementary approaches:

• Yeast Two-Hybrid (Y2H) screening:

  • Clone Os03g0776000 into a suitable bait vector (e.g., pGBKT7)

  • Screen against a rice cDNA library cloned into a prey vector (e.g., pGADT7)

  • Verify positive interactions through reporter gene assays

  • Further confirm using directed Y2H with specific candidates

  • This approach successfully identified interactions between GSK2 and DLT

• GST pull-down assays:

  • Express Os03g0776000 as a GST or MBP fusion protein

  • Express potential interacting proteins with a different tag

  • Perform in vitro binding assays

  • Analyze pulled-down proteins by Western blotting

  • This method can validate direct protein-protein interactions

• Bimolecular Fluorescence Complementation (BiFC):

  • Clone Os03g0776000 into a vector containing the N-terminal half of YFP (nYFP)

  • Clone candidate interacting proteins into a vector with C-terminal half of YFP (cYFP)

  • Co-transform into rice protoplasts

  • Observe fluorescence using confocal microscopy

  • This visualizes interactions in a cellular context

• Co-immunoprecipitation from plant tissues:

  • Immunoprecipitate Os03g0776000 using specific antibodies

  • Analyze co-precipitated proteins by:
    a) Western blotting for known candidates
    b) Mass spectrometry for unbiased discovery

  • Confirm with reciprocal IP experiments

• Protein interaction networks analysis:

  • Create a comprehensive protein interaction map

  • Connect identified interactors to known signaling pathways

  • Perform functional classification of interacting proteins

  • Identify regulatory hubs and signaling modules

This multi-faceted approach can reveal how Os03g0776000 functions within larger signaling networks and how these interactions are regulated during development and in response to environmental cues.

What experimental design is optimal for studying Os03g0776000 across different developmental stages?

To comprehensively study Os03g0776000 across different developmental stages, implement this experimental design:

• Systematic tissue and developmental stage sampling:

  Developmental Stage	Tissues to Sample
  Germination (1-7 days)	Whole seedling, coleoptile, primary root
  Vegetative (2-6 weeks)	Young leaves, mature leaves, tillers, nodes, internodes, roots
  Reproductive (7-12 weeks)	Flag leaf, panicle, flowers, developing seeds
  Maturation (13-16 weeks)	Maturing seeds, senescing leaves

• Protein expression analysis:

  • Extract total protein from each sample

  • Perform Western blotting with Os03g0776000 antibodies

  • Quantify relative protein levels

  • Analyze phosphorylation status (as mentioned in previous question)

  • Research with DLT showed significant differences between young and mature leaves

• Transcript level correlation:

  • Extract RNA from the same tissue samples

  • Perform qRT-PCR for Os03g0776000 using methods similar to those described for other genes

  • Compare transcript and protein levels to identify post-transcriptional regulation

  • Use ubiquitin-conjugating enzyme gene (Os02g0634800) as an internal control

• Hormone response analysis across stages:

  • From each developmental stage, collect tissue samples

  • Treat with brassinolide (1 μM) for 1-2 hours

  • Extract proteins and analyze Os03g0776000 levels and phosphorylation

  • Determine if hormone sensitivity changes during development

• Immunolocalization studies:

  • Prepare tissue sections from different developmental stages

  • Perform immunohistochemistry with Os03g0776000 antibodies

  • Analyze changes in protein localization patterns

  • Co-stain with markers for different cellular compartments

• Genetic complementation analysis:

  • For functional validation, transform mutant lines with Os03g0776000 under stage-specific promoters

  • Assess phenotypic rescue at different developmental stages

This comprehensive experimental design will reveal how Os03g0776000 expression, modification, and function change throughout rice development, providing insights into its role in growth regulation.

How can Os03g0776000 antibodies be used to investigate signaling crosstalk between hormonal pathways?

To investigate signaling crosstalk between hormonal pathways using Os03g0776000 antibodies, implement these methodological approaches:

• Hormone treatment combinations:

  • Treat rice seedlings with combinations of hormones:

    • Brassinosteroids (BR): 0.1-1 μM brassinolide

    • Strigolactones (SL): 1-10 μM GR24 (synthetic strigolactone)

    • Auxin: 1-10 μM IAA or NAA

    • Gibberellins: 1-10 μM GA3

  • Conduct both co-treatments and sequential treatments

  • Extract proteins and analyze Os03g0776000 levels and phosphorylation status

  • Research indicates interactions between BR signaling (where DLT functions) and other hormone pathways

• Hormone biosynthesis/signaling mutant analysis:

  • Obtain rice mutants with defects in different hormone pathways:

    • BR: d61-1 (BR receptor mutant)

    • SL: d10, d14, d27 (SL biosynthesis/signaling mutants)

    • Auxin: Various auxin signaling mutants

  • Analyze Os03g0776000 protein levels and modifications in these backgrounds

  • Compare responses to hormone treatments across genotypes

• Protein complex analysis across hormone treatments:

  • Immunoprecipitate Os03g0776000 after various hormone treatments

  • Identify co-precipitated proteins by mass spectrometry

  • Determine if hormone treatments alter protein interactions

  • Compare with known hormone signaling components

• Phosphorylation dynamics in response to multiple hormones:

  • Treat plants with hormone biosynthesis inhibitors:

    • Brassinazole (BR inhibitor)

    • TIBA (auxin transport inhibitor)

  • Then apply different hormones

  • Monitor Os03g0776000 phosphorylation changes

  • Determine if one hormone pathway affects modification by another

• Gene expression analysis:

  • After hormone treatments, analyze expression of:

    • Os03g0776000 itself

    • Known BR-responsive genes

    • Markers for other hormone pathways

  • Use qRT-PCR protocols as described for other genes

  • Correlate with Os03g0776000 protein levels

This integrated approach will reveal how Os03g0776000 functions at the intersection of multiple hormone signaling pathways, providing insights into how plants coordinate different growth regulators.

What criteria should be used to validate the specificity of Os03g0776000 antibodies?

To ensure proper validation of Os03g0776000 antibodies, implement these comprehensive validation criteria:

• Western blot validation with genetic controls:

  • Wild-type rice tissues (positive control)

  • Os03g0776000 knockout or knockdown lines (negative control)

  • Os03g0776000 overexpression lines (enhanced signal control)

  • Detection of bands at the expected molecular weight (~65 kDa)

  • Similar approach was used for DLT antibody validation

• Immunoprecipitation-mass spectrometry validation:

  • Immunoprecipitate proteins using the Os03g0776000 antibody

  • Analyze by mass spectrometry

  • Confirm that Os03g0776000 is the predominant protein detected

  • Identify any cross-reacting proteins

• Competitive binding assays:

  • Pre-incubate antibody with:
    a) Recombinant Os03g0776000 protein (should block signal)
    b) Unrelated protein (should not affect signal)

  • Use pre-incubated antibody in Western blot or immunostaining

  • Signal should be reduced/eliminated with specific competition

• Cross-reactivity assessment:

  • Test antibody against:
    a) Closely related rice proteins
    b) Os03g0776000 orthologs from other grass species

  • Document any cross-reactivity

  • Consider this information when interpreting results

• Phosphorylation-specific validation:

  • Treat protein samples with phosphatase

  • Verify that slower-migrating bands disappear

  • This approach confirmed phosphorylation status of DLT

• Immunohistochemistry controls:

  • Include peptide competition controls

  • Use secondary antibody-only controls

  • Compare patterns with known expression domains

• Validation across multiple applications:

  • Document performance in different techniques:
    a) Western blotting
    b) Immunoprecipitation
    c) Immunohistochemistry
    d) ELISA (if applicable)

A validation report should include these criteria with quantitative assessments where possible. This ensures reliable interpretation of experimental results obtained using Os03g0776000 antibodies.

How should researchers optimize antibody dilutions for different experimental applications?

Optimizing antibody dilutions for different applications requires systematic titration. Follow these methodological approaches:

• Western blotting optimization:

  Dilution Range	Recommended Testing Protocol
  1:500 - 1:5,000	Prepare a gradient of primary antibody dilutions
  	Use identical protein samples (20-50 μg)
  	Maintain consistent secondary antibody (1:5,000)
  	Evaluate signal-to-background ratio
  	Optimal dilution: strongest specific signal with minimal background

• Immunohistochemistry optimization:

  Dilution Range	Recommended Testing Protocol
  1:50 - 1:500	Test on identical tissue sections
  	Include positive and negative control tissues
  	Maintain consistent secondary antibody (1:200)
  	Evaluate staining intensity and specificity
  	Optimal dilution: clear specific staining with minimal background

• Immunoprecipitation optimization:

  Antibody Amount	Recommended Testing Protocol
  1-10 μg per mg of protein	Test varying amounts of antibody
  	Use consistent amounts of protein extract
  	Evaluate IP efficiency by Western blotting
  	Optimal amount: maximum target precipitation with minimum antibody

• ELISA optimization:

  Dilution Range	Recommended Testing Protocol
  1:100 - 1:10,000	Prepare a two-fold dilution series
  	Test against a standard curve of antigen
  	Plot absorbance vs. antibody dilution
  	Optimal dilution: within linear range of detection

• Factors affecting optimal dilution:

  • Antibody affinity and specificity

  • Antigen abundance in sample

  • Detection system sensitivity

  • Sample preparation method

  • Tissue fixation (for immunohistochemistry)

  • Background interference from sample components

• Documentation for reproducibility:

  • Record lot number of antibody

  • Document exact dilution and incubation conditions

  • Note any modifications to standard protocols

  • Include validation controls in each experiment

This systematic approach ensures optimal antibody performance while minimizing waste of valuable reagents. Researchers should maintain detailed records of optimization experiments for future reference.

What strategies can overcome common technical challenges with plant protein detection?

To overcome common technical challenges with plant protein detection when using Os03g0776000 antibodies, implement these specialized strategies:

• Effective protein extraction from plant tissues:

  • Add 2% PVPP (polyvinylpolypyrrolidone) to extraction buffer to remove phenolic compounds

  • Include 1-2% β-mercaptoethanol to prevent oxidation

  • Add protease inhibitor cocktail at 2× recommended concentration

  • For phosphoproteins, add phosphatase inhibitors:

    • 10 mM sodium fluoride

    • 1 mM sodium orthovanadate

    • 50 mM β-glycerophosphate

  • Use HEPES-based buffers (pH 7.5) instead of Tris for more stable pH in plant extracts

• Reducing background in Western blotting:

  Issue	Solution
  High background	- Increase blocking time to 2 hours or overnight
  	- Try different blocking agents (milk, BSA, fish gelatin)
  	- Add 0.05-0.1% SDS to antibody dilution buffer
  	- Increase Tween-20 concentration in wash buffer to 0.2%
  	- Use vacuum filtration for antibody solutions

• Improving protein separation:

  • Remove interfering compounds through:

    • TCA/acetone precipitation

    • Phenol extraction followed by ammonium acetate precipitation

  • For high-resolution separation of phosphorylated forms:

    • Use Phos-tag™ acrylamide gels

    • Run at lower voltage (80-100V)

    • Extend running time by 25-50%

• Enhancing immunoprecipitation efficiency:

  • Pre-clear lysates extensively (2× with protein A/G beads)

  • Add 0.1% BSA to IP buffer to reduce non-specific binding

  • Increase salt concentration (250-300 mM NaCl) to reduce ionic interactions

  • Cross-link antibody to beads to prevent antibody contamination in eluted samples

  • Use gentle elution with competing peptide rather than boiling in SDS

• Improving immunohistochemistry in plant tissues:

  • Optimize fixation (4% paraformaldehyde, 24 hours at 4°C)

  • Perform extensive vacuum infiltration to ensure fixative penetration

  • Use cell wall degrading enzymes (0.1% pectolyase, 1% cellulase) before antibody incubation

  • Extend primary antibody incubation to 48 hours at 4°C

  • Use tissue sections of 5-7 μm thickness for optimal antibody penetration

  • Include 0.1% Triton X-100 in all buffers to enhance penetration

These specialized techniques address the unique challenges of plant biochemistry and physiology, significantly improving detection of Os03g0776000 protein in various experimental applications.

How should researchers interpret multiple bands in Western blots with Os03g0776000 antibodies?

The interpretation of multiple bands in Western blots with Os03g0776000 antibodies requires careful analysis and validation. Based on research with related proteins like DLT, follow this decision framework:

• Identification of phosphorylated forms:

  • DLT shows two major bands in mature leaves: one corresponding to phosphorylated and another to dephosphorylated form

  • To verify if higher molecular weight bands represent phosphorylated Os03g0776000:

    • Treat protein samples with calf intestinal alkaline phosphatase (CIP)

    • If bands disappear after treatment, they likely represent phosphorylated forms

    • Analyze migration patterns (phosphorylated forms typically migrate more slowly)

• Developmental regulation analysis:

  • Compare band patterns across different developmental stages

  • Young leaves may show predominantly one form, while mature leaves show multiple forms

  • Document changes in the ratio of different forms during development

• Response to hormone treatment:

  • Monitor changes in band patterns after brassinolide treatment

  • Brassinolide typically increases the dephosphorylated form and decreases phosphorylated forms

  • Quantify the ratio of band intensities before and after treatment

• Distinguishing degradation products from functional forms:

  • Degradation products: Usually multiple bands of decreasing molecular weight

  • Functional variants: Consistent pattern of specific bands

  • Add protease inhibitors during extraction to minimize degradation

  • Compare fresh samples with frozen/thawed samples to identify degradation artifacts

• Analysis framework for common band patterns:

  Band Pattern	Likely Interpretation	Validation Approach
  Single band at expected MW	Non-modified protein	Verify size matches prediction
  Two distinct bands	Phosphorylated and non-phosphorylated forms	Phosphatase treatment
  Multiple closely spaced bands	Multiple phosphorylation states	Phosphatase treatment, Phos-tag gels
  Multiple widely spaced bands	Potential degradation or cross-reactivity	Protease inhibitors, peptide competition
  High MW smear	Potential ubiquitination or SUMOylation	Treatment with deubiquitinating enzymes

• Quantitative analysis considerations:

  • For phosphorylation studies, report the ratio of phosphorylated to non-phosphorylated forms

  • For expression studies, sum the intensity of all specific bands

  • Include appropriate loading controls (actin, tubulin, or GAPDH)

  • Use image analysis software to quantify band intensities

What criteria determine successful protein-protein interaction studies with Os03g0776000?

When evaluating protein-protein interaction studies involving Os03g0776000, apply these comprehensive criteria to ensure valid and reliable results:

• Essential controls for co-immunoprecipitation experiments:

  • Input control: Verify presence of both proteins in starting material

  • Negative control: Immunoprecipitation with pre-immune serum or IgG

  • Reciprocal IP: Confirm interaction by IP with antibodies against interacting partner

  • Competition control: Addition of excess antigen peptide should abolish specific IP

  • These controls were critical for validating GSK2-DLT interactions

• Validation across multiple interaction detection methods:

  Method	Success Criteria	Strengths/Limitations
  Co-IP	Specific co-precipitation resistant to stringent washing	Detects native complexes but may include indirect interactions
  GST pull-down	Interaction between purified components with specific dose-dependency	Confirms direct interaction but may miss context-dependent interactions
  Yeast two-hybrid	Growth on selective media and reporter gene activation	High-throughput but prone to false positives
  BiFC	Specific fluorescence signal in relevant cellular compartment	Visualizes interaction in cellular context but may force interactions

• Evidence for biological relevance:

  • Interaction occurs at physiologically relevant concentrations

  • Proteins co-localize in same subcellular compartment

  • Interaction dynamics correlate with biological processes

  • Genetic evidence supports functional relationship (e.g., similar mutant phenotypes)

  • Interaction is regulated by relevant stimuli (e.g., hormone treatment)

• Functional implications assessment:

  • Determine whether interaction affects:

    • Protein stability or degradation

    • Enzymatic activity

    • Phosphorylation state

    • Subcellular localization

    • DNA binding (for transcription factors)

  • Research with DLT shows that interaction with GSK2 leads to phosphorylation

• Quantitative criteria for specific techniques:

  • SPR: Ka, Kd, and KD values with chi-square values <10%

  • FRET: FRET efficiency >5% above negative controls

  • BiFC: Signal-to-background ratio >3:1

  • Co-IP: Enrichment of partner protein >2-fold relative to control IP

These multi-dimensional criteria ensure that reported interactions between Os03g0776000 and other proteins represent biologically meaningful relationships rather than experimental artifacts.

How can contradictory results in Os03g0776000 research be reconciled through methodological improvements?

When confronted with contradictory results in Os03g0776000 research, implement these methodological strategies to reconcile discrepancies:

• Standardization of experimental materials:

  • Use consistent rice varieties/cultivars

  • Define precise developmental stages using standardized metrics

  • Control growth conditions rigorously (temperature, light, humidity)

  • Document soil composition or nutrient solution formulation

  • These factors can significantly affect protein expression and modification patterns

• Antibody-related reconciliation strategies:

  Discrepancy Source	Resolution Approach
  Different antibody epitopes	Map epitope locations and phosphorylation sites
  Varying antibody specificity	Perform side-by-side validation with the same controls
  Inconsistent detection sensitivity	Standardize extraction methods and detection systems
  Clone-dependent variation	Specify antibody clone and lot numbers in all reports

• Hormone treatment standardization:

  • Define precise concentrations, duration, and application methods

  • Document hormone source and purity

  • Control for carrier solvents (e.g., ethanol, DMSO)

  • Verify hormone activity using known bioassays

  • These factors affect brassinosteroid responses that modify Os03g0776000/DLT phosphorylation

• Phosphorylation analysis reconciliation:

  • Use multiple detection methods in parallel:

    • Mobility shift analysis

    • Phosphatase treatment

    • Phospho-specific antibodies (if available)

    • Mass spectrometry

  • Implement Phos-tag™ gels for higher resolution of phosphorylated forms

  • Precisely define extraction buffers and phosphatase inhibitor composition

• Protein-protein interaction verification framework:

  • Implement at least three independent interaction methods

  • Define interaction strength quantitatively when possible

  • Map interaction domains to resolve partial contradictions

  • Consider dynamic/condition-dependent interactions

  • Similar approaches validated GSK2-DLT interactions

• Genetic background considerations:

  • Test interactions in multiple genetic backgrounds

  • Document any modifiers that affect interactions

  • Generate isogenic lines for cleaner comparisons

  • Consider redundancy with related genes (e.g., GSK family members)

• Meta-analysis approach for literature reconciliation:

  • Weight evidence based on methodological rigor

  • Identify patterns in conflicting results

  • Develop testable hypotheses to resolve contradictions

  • Design decisive experiments addressing specific discrepancies

By implementing these methodological improvements and standardization approaches, researchers can resolve contradictions in Os03g0776000 research and develop a more consistent understanding of its function.